|2018||PhD||Epidemiology||Johns Hopkins Bloomberg School of Public Health||USA / Baltimore|
|2017||MHS||Biostatistics||Johns Hopkins Bloomberg School of Public Health||USA / Baltimore|
|2012||MSPH||International Health||Johns Hopkins Bloomberg School of Public Health||USA / Baltimore|
|2010||BS||Chemistry||Duke University||USA / Durham|
Current Research Projects
Risk prediction and biomarkers for early detection of lung cancer
HPV biomarkers for early detection of oropharyngeal and anogenital cancers
Robbins HA, Callister M, Sasieni P, et al. Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol. Lancet Respir Med 2019;7(8).
Robbins HA, Berg CD, Cheung LC, Chaturvedi AK, Katki HA. Identification of candidates for longer lung cancer screening intervals following a negative low-dose computed tomography result. J Natl Cancer Inst 2019;111(9):996–9.
Robbins HA, Strickler HD, Massad LS, et al. Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach. AIDS 2017;31(7):1035–44.
Robbins HA, Pfeiffer RM, Shiels MS, Li J, Hall HI, Engels EA. Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst 2015;107(4).
Robbins HA, Clarke CA, Arron ST, et al. Melanoma risk and survival among organ transplant recipients. J Invest Dermatol 2015;135(11):2657–65.